Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018555496> ?p ?o ?g. }
- W2018555496 endingPage "959" @default.
- W2018555496 startingPage "945" @default.
- W2018555496 abstract "Abstract Hyperglycemic control in diabetes is key to preventing the development and progression of vascular complications such as retinopathy, nephropathy and neuropathy. Increased activation of the diacylglycerol (DAG)‐protein kinase C (PKC) signal transduction pathway has been identified in vascular tissues from diabetic animals, and in vascular cells exposed to elevated glucose. Vascular abnormalities associated with glucose‐induced PKC activation leading to increased synthesis of DAG include altered vascular blood flow, extracellular matrix deposition, basement membrane thickening, increased permeability and neovascularization. Preferential activation of the PKCβ isoform by elevated glucose is reported to occur in a variety of vascular tissues. This has lead to the development of LY333531, a PKCβ isoform specific inhibitor, which has shown potential in animal models to be an orally effective and nontoxic therapy able to produce significant improvements in diabetic retinopathy, nephropathy, neuropathy and cardiac dysfunction. Additionally, the antioxidant vitamin E has been identified as an inhibitor of the DAG‐PKC pathway, and shows promise in reducing vascular complications in animal models of diabetes. Given the overwhelming evidence indicating a role for PKC activation in contributing to the development of diabetic vascular complications, pharmacological therapies that can modulate this pathway, particularly with PKC isoform selectivity, show great promise for treatment of vascular complications, even in the presence of hyperglycemia. Diabet. Med. 18, 945–959 (2001)" @default.
- W2018555496 created "2016-06-24" @default.
- W2018555496 creator A5009528569 @default.
- W2018555496 creator A5080738002 @default.
- W2018555496 creator A5081293390 @default.
- W2018555496 date "2001-12-01" @default.
- W2018555496 modified "2023-10-18" @default.
- W2018555496 title "Protein kinase C and the development of diabetic vascular complications" @default.
- W2018555496 cites W1524337940 @default.
- W2018555496 cites W1551177506 @default.
- W2018555496 cites W1562404007 @default.
- W2018555496 cites W1583483795 @default.
- W2018555496 cites W1586323548 @default.
- W2018555496 cites W1602290343 @default.
- W2018555496 cites W1604033142 @default.
- W2018555496 cites W1604542334 @default.
- W2018555496 cites W1670731304 @default.
- W2018555496 cites W1786056430 @default.
- W2018555496 cites W1810991871 @default.
- W2018555496 cites W1927620573 @default.
- W2018555496 cites W1932654578 @default.
- W2018555496 cites W1949684180 @default.
- W2018555496 cites W1966234811 @default.
- W2018555496 cites W1966419887 @default.
- W2018555496 cites W1967172766 @default.
- W2018555496 cites W1969495982 @default.
- W2018555496 cites W1969949240 @default.
- W2018555496 cites W1970539529 @default.
- W2018555496 cites W1971202836 @default.
- W2018555496 cites W1971695868 @default.
- W2018555496 cites W1975995627 @default.
- W2018555496 cites W1978414192 @default.
- W2018555496 cites W1978444547 @default.
- W2018555496 cites W1978747049 @default.
- W2018555496 cites W1981015625 @default.
- W2018555496 cites W1985013152 @default.
- W2018555496 cites W1988143227 @default.
- W2018555496 cites W1990026949 @default.
- W2018555496 cites W1990675333 @default.
- W2018555496 cites W1993047367 @default.
- W2018555496 cites W1993049332 @default.
- W2018555496 cites W1993282564 @default.
- W2018555496 cites W1996424575 @default.
- W2018555496 cites W1997926000 @default.
- W2018555496 cites W1998539941 @default.
- W2018555496 cites W1999987807 @default.
- W2018555496 cites W2000892619 @default.
- W2018555496 cites W2001135537 @default.
- W2018555496 cites W2002938395 @default.
- W2018555496 cites W2005463323 @default.
- W2018555496 cites W2005981619 @default.
- W2018555496 cites W2008770524 @default.
- W2018555496 cites W2011557080 @default.
- W2018555496 cites W2012973441 @default.
- W2018555496 cites W2012978268 @default.
- W2018555496 cites W2014462765 @default.
- W2018555496 cites W2014501553 @default.
- W2018555496 cites W2016121744 @default.
- W2018555496 cites W2016953472 @default.
- W2018555496 cites W2021087951 @default.
- W2018555496 cites W2021277702 @default.
- W2018555496 cites W2023377229 @default.
- W2018555496 cites W2024764014 @default.
- W2018555496 cites W2025732390 @default.
- W2018555496 cites W2026885774 @default.
- W2018555496 cites W2027478328 @default.
- W2018555496 cites W2030060280 @default.
- W2018555496 cites W2033719920 @default.
- W2018555496 cites W2034225514 @default.
- W2018555496 cites W2036628331 @default.
- W2018555496 cites W2039617541 @default.
- W2018555496 cites W2040382523 @default.
- W2018555496 cites W2043406584 @default.
- W2018555496 cites W2045687167 @default.
- W2018555496 cites W2045926020 @default.
- W2018555496 cites W2046429157 @default.
- W2018555496 cites W2049401019 @default.
- W2018555496 cites W2051199054 @default.
- W2018555496 cites W2052939510 @default.
- W2018555496 cites W2053666944 @default.
- W2018555496 cites W2055168506 @default.
- W2018555496 cites W2058744360 @default.
- W2018555496 cites W2059357264 @default.
- W2018555496 cites W2060382299 @default.
- W2018555496 cites W2060476962 @default.
- W2018555496 cites W2061202476 @default.
- W2018555496 cites W2062548885 @default.
- W2018555496 cites W2065086918 @default.
- W2018555496 cites W2070606991 @default.
- W2018555496 cites W2070815949 @default.
- W2018555496 cites W2071187274 @default.
- W2018555496 cites W2071206965 @default.
- W2018555496 cites W2073637063 @default.
- W2018555496 cites W2075553837 @default.
- W2018555496 cites W2079047912 @default.
- W2018555496 cites W2081268562 @default.
- W2018555496 cites W2081615229 @default.
- W2018555496 cites W2084618229 @default.